Skip to main content
Log in

Sentinel node biopsy in breast cancer

  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Axillary lymphnode dissection (ALND) for breast cancer patients provides local control and information for the determination of the type of adjuvant therapy. The benefit of axillary surgery itself for survival is considered to be limited to patients with positive nodes. Sentinel node biopsy is a recently developed, minimally invasive technique for precisely predicting axillary nodal status. As this technique has less morbidity and greater accuracy than ALND, it replaces ALND for patients with node negative breast cancer. In this report, we outline the current status of sentinel node biopsy for breast cancer patients and introduce our preliminary results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

SNB:

Sentinel node biopsy

ALND:

Axillary lymph-node dissection

References

  1. Early Breast Cancer Trialists’ Collaborative Group: Polychemotherapy for early breast cancer; An overview of the randomized trials.Lancet 352:930–942, 1998.

    Article  Google Scholar 

  2. Fisher B, Redmond C, Fisher ER,et al: Ten year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with and without irradiation.N Engl J Med 312:674–681, 1985.

    PubMed  CAS  Google Scholar 

  3. Haagensen C: The surgical treatment of mammary carcinoma. In: Disease of the Breast, 2nd ed, WB Saunders, Philadelphia, pp704–709, 1971.

    Google Scholar 

  4. Renolleau C, Merviel P, Clough KB,et al: Isolated axillary recurrences after conservative treatment of breast cancer.Eur J Cancer 32A:617–621, 1996.

    Article  PubMed  CAS  Google Scholar 

  5. Halverson KJ, Taylor ME, Perez CA,et al: Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer.Int J Radiat Oncol Biol Phys 26:593–599, 1993.

    PubMed  CAS  Google Scholar 

  6. Graverson MP, Blichert-Toft B, Andersen JA,et al: Breast Cancer; Risk of axillary recurrence in node negative patients following partial dissection of the axilla.Eur J Surg Oncol 14:407–412, 1988.

    Google Scholar 

  7. Kjaergaard J, Blichert-Toft B, Andersen JA,et al: Probability of false negative nodal status in conjunction with partial axillary dissection in breast cancer.Br J Surg 72:365–367, 1985.

    Article  PubMed  CAS  Google Scholar 

  8. Hayward J: The Guy’s trial of treatment of early breast cancer.World J Surg 1:314–316, 1998.

    Article  Google Scholar 

  9. Cabanes PA, Salmon RJ, Vilcoq JR,et al: Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer.Lancet 339:1245–1248, 1992.

    Article  PubMed  CAS  Google Scholar 

  10. Morton D, Wen D-R, Wong J,et al: Technical details of intraoperative lymphatic mapping for early stage melanoma.Arch Surg 127:392–399, 1992.

    PubMed  CAS  Google Scholar 

  11. Giuliano AE, Kirgan DM, Guenther JM,et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer.Ann Surg 220:391–401, 1994.

    Article  PubMed  CAS  Google Scholar 

  12. Giuliano AE, Jones RC, Brennan M,et al: Sentinel lymphadenectomy in breast cancer.J Clin Oncol 15:2345–2350, 1997.

    PubMed  CAS  Google Scholar 

  13. Guenther JM, Krishnamoorthy M, Tan LR,et al: Sentinel lymphadenectomy for breast cancer in a community managed care setting.Cancer J Sci Am 3:336–340, 1997.

    PubMed  CAS  Google Scholar 

  14. Dale PS, Williams JT: Axillary staging utilizing selective sentinel lymphadenectomy for patients with invasive breast carcinoma.Am Surg 64:28–31, 1998.

    PubMed  CAS  Google Scholar 

  15. Flett MM, Going JJ, Stanton PD,et al: Sentinel node localization in patients with breast cancer.Br J Cancer 85:991–993, 1998.

    CAS  Google Scholar 

  16. Motomura K, Inaji H, Komoike Y,et al: Sentinel node biopsy in breast cancer patients with clinically negative lymph-nodes.Breast Cancer 6:259–262, 1999.

    Article  PubMed  Google Scholar 

  17. Motomura K, Inaji H, Komoike Y,et al: Sentinel node biopsy guided by indocyanin green dye in breast cancer patients.Jpn J Clin Oncol. In press.

  18. Krag DN, Weaver DL, Alex JC,et al: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe.Surg Oncol 2:335–339, 1993.

    Article  PubMed  CAS  Google Scholar 

  19. Veronesi U, Paganelli G, Galimberti V,et al: Sentinelnode biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.Lancet 349:1864–1867, 1997.

    Article  PubMed  CAS  Google Scholar 

  20. Albertini JJ, Lyman GH, Cox C,et al: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.JAMA 276:1818–1822, 1996.

    Article  PubMed  CAS  Google Scholar 

  21. Cox CE, Pendas S, Cox JM,et al: Guidlines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.Ann Surg 227:645–653, 1998.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Motomura, K., Inaji, H., Komoike, Y. et al. Sentinel node biopsy in breast cancer. Breast Cancer 6, 289–291 (1999). https://doi.org/10.1007/BF02966441

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02966441

Key words

Navigation